Glycologix, Inc., 2025-12-29
An SEC Form D private-offering notice from Beverly, MA, a $1,000,000 filer-stated offering target in Biotech. Filed 2025-12-29. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing locally delivered biopolymers for protection and repair of soft tissues, lead program targets interstitial cystitis.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Tive, Inc., 2026-01-02, $20M, Boston, MA
- Double Blind Bio Inc., 2025-12-29, $5.6M, San Francisco, CA
- POSEIDON'S FORGE, INC., 2025-12-31, $500K, Rehoboth, MA
- SLAM BioTherapeutics, Inc., 2025-12-29, $4M, Westlake Village, CA
- Genialis, Inc., 2025-12-31, $3M, Boston, MA
- Phenomix Sciences, Inc., 2025-12-29, $5M, Menlo Park, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.